Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ATNXQ similar filings
- 3 Sep 21 Departure of Directors or Certain Officers
- 20 Aug 21 Entry into a Material Definitive Agreement
- 5 Aug 21 Athenex Provides Second Quarter 2021 Corporate and Financial Update
- 20 Jul 21 Financial Statements and Exhibits
- 23 Jun 21 Departure of Directors or Certain Officers
- 6 May 21 Athenex Provides First Quarter 2021 Corporate and Financial Update
- 5 May 21 Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform
Filing view
External links
Exhibit 23.1
Consent of Independent Auditors
We consent to the incorporation by reference in Registration Statements on Form S-3 (Nos. 333-227492, 333-232772, 333-236104, and 333-241665) and on Form S-8 (Nos. 333-218984 and 333-241666) of Athenex, Inc. of our report dated July 9, 2021, relating to the financial statements of Kuur Therapeutics Inc., appearing in the Current Report on Form 8-K/A of Athenex, Inc.
/s/ Moss Adams LLP
Denver, Colorado
July 19, 2021